Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma

Status:
Unknown status

Trial end date:
2010-02-01

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the safety and biologically active dose of TM-601 in adult patients with recurrent malignant glioma.

Phase 1

TransMolecular